Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-ONRC-10000763Phase 4Completed
Phase 4, open-label trial of micafungin in fungemia, aspergillosis and candidiasis (3 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Micafungin sodium plasma concentration. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-ONRC-10000763.